As observed in this study and supported by several previous reports, the stem-like CD44+/CD133+ colon cancer cells are chemo-resistant, a characteristic that is enhanced by IL-6 stimulation and the subsequent FRA1 deacetylation. The gene discussed is PROM1; the disease is malignant colon neoplasm.